Ahmedabad-Based Zydus Cadila's Covid Vaccine Awaits Govt Approval

After conducting the largest clinical trials in more than 50 centers, Zydus Cadila's three-dose Covid vaccine "ZyCoV-D" may soon get the government's approval for emergency use in India. The Gujarat-based pharmaceutical company has been listed for emergency use authorization (EAU) with the Indian Drug regulator and is likely to produce around 10-12 crore doses in a year. Reportedly, the ZyCoV-D vaccination will be administered to the adults first.